Innoviva (INVA) EBT Margin (2011 - 2026)
Innoviva posted quarterly EBT Margin of 239.36% for Q1 2026, up 28290.0% year-on-year from N/an in Q1 2025, and up 118.79% on a QoQ basis from 1274.01% in Q4 2025.
Innoviva (INVA) has 16 years of EBT Margin data on file, last reported at 239.36% in Q1 2026.
- For the quarter ending Q1 2026, EBT Margin rose 28290.0% year-over-year to 239.36%; the trailing twelve-month figure through Mar 2026 stood at 127.34% (up 15655.0% YoY), and the FY2025 full-year result was 79.51%, up 6910.0% from the prior year.
- EBT Margin for Q1 2026 stood at 239.36%, up from 1274.01% in the prior quarter.
- Across five years, EBT Margin topped out at 22032.62% in Q3 2022 and bottomed at 1274.01% in Q4 2025.
- The 5-year median for EBT Margin is 90.74% (2025), against an average of 2005.03%.
- The widest annual swing landed in 2022, when EBT Margin soared 2190675 bps; it then plunged 2190482 bps in 2023.
- A 5-year view of EBT Margin shows it stood at 982.68% in 2022, then soared by 56 bps to 430.5% in 2023, then sank by 98 bps to 853.36% in 2024, then plunged by 49 bps to 1274.01% in 2025, then soared by 119 bps to 239.36% in 2026.
- The last three EBT Margin figures came in at 239.36% (Q1 2026), 1274.01% (Q4 2025), and 90.74% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -6.40% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 41.95% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 23.05% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 18.99% |
| 10 | Innoviva | 1.60 Bn | 992.84 Mn | 75.83 Mn | 239.36% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 239.36% |
| Dec 31, 2025 | -1,274.01% |
| Sep 30, 2025 | 90.74% |
| Jun 30, 2025 | 72.39% |
| Mar 31, 2025 | -43.54% |
| Dec 31, 2024 | -853.36% |
| Sep 30, 2024 | 7.65% |
| Jun 30, 2024 | -39.32% |
| Mar 31, 2024 | 4,671.22% |
| Dec 31, 2023 | -430.50% |
| Sep 30, 2023 | 127.79% |
| Jun 30, 2023 | 592.35% |
| Mar 31, 2023 | 5,168.34% |
| Dec 31, 2022 | -982.68% |
| Sep 30, 2022 | 22,032.62% |
| Jun 30, 2022 | 1,088.42% |
| Mar 31, 2022 | 3,617.96% |
| Dec 31, 2021 | -611.53% |
| Sep 30, 2021 | 125.87% |
| Jun 30, 2021 | 11,659.16% |
| Mar 31, 2021 | 12,141.74% |
| Dec 31, 2020 | 18,007.54% |
| Sep 30, 2020 | 56.92% |
| Jun 30, 2020 | 149.62% |
| Mar 31, 2020 | 120.60% |
| Dec 31, 2019 | 92.49% |
| Sep 30, 2019 | 87.61% |
| Jun 30, 2019 | 88.12% |
| Mar 31, 2019 | 87.94% |
| Dec 31, 2018 | 91.59% |
| Sep 30, 2018 | 81.33% |
| Jun 30, 2018 | 84.39% |
| Mar 31, 2018 | 57.90% |
| Dec 31, 2017 | 43.60% |
| Sep 30, 2017 | 69.96% |
| Jun 30, 2017 | 61.36% |
| Mar 31, 2017 | 41.48% |
| Dec 31, 2016 | 56.94% |
| Sep 30, 2016 | 44.96% |
| Jun 30, 2016 | 39.66% |
| Mar 31, 2016 | 18.48% |
| Dec 31, 2015 | 18.83% |
| Sep 30, 2015 | -33.80% |
| Jun 30, 2015 | -73.30% |
| Mar 31, 2015 | -154.68% |
| Dec 31, 2014 | -218.76% |
| Sep 30, 2014 | -2,157.06% |
| Jun 30, 2014 | -2,127.73% |
| Mar 31, 2014 | -2,074.62% |
| Dec 31, 2013 | -603.80% |
| Sep 30, 2013 | -2,278.07% |
| Jun 30, 2013 | -116.57% |
| Mar 31, 2013 | -2,718.46% |
| Dec 31, 2012 | 34.96% |
| Sep 30, 2012 | -2,426.01% |
| Jun 30, 2012 | -7,097.51% |
| Mar 31, 2012 | 67.24% |
| Dec 31, 2011 | -690.17% |
| Sep 30, 2011 | -476.22% |
| Jun 30, 2011 | -392.00% |
| Mar 31, 2011 | -360.32% |